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Obsessive Compulsive Symptoms (OCS) and Disorder (OCD) occur frequently in patients with schizo-
phrenia. Nevertheless the impact of OCS/OCD on clinical characteristics and outcome of schizophrenia
remains controversial. The aim of the present study is to examine the effect of obsessive–compulsive
dimension on symptom expression and functioning in schizophrenia. Sixty patients affected by schizo-
phrenia completed the SCID-IV, the Positive and Negative Syndrome Scale, the Yale-Brown Obsessive–
Compulsive Scale, the Social and Occupational Functioning Assessment Scale and the Strauss and Car-
penter Level of Functioning Rating Scale. Obsessive–compulsive dimension was associated neither with
positive or disorganization symptoms nor with negative symptoms. By contrast, it adversely affected
levels of functioning, with a major impact exerted by compulsions rather than obsessions. Obsessive–
compulsive dimension appears to be independent from negative and positive symptoms of schizo-
phrenia and independently decreases social functioning.
& 2015 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Obsessive Compulsive Symptoms (OCS) and Disorder (OCD)
occur frequently in patients with schizophrenia with a rate varying
from 10% to 64% for OCS and from 7.8% to 31.7% for OCD (de Haan
et al., 2013a, 2013b). Nevertheless the impact of OCS/OCD on
clinical characteristics and outcome of schizophrenia remains
controversial (Poyurovsky et al., 2012; de Haan et al., 2013a,
2013b). Whereas early studies (Jahrreiß, 1926; Stengel, 1945; Ro-
sen, 1957) considered OC features as a compensatory attempt to
reduce psychotic symptoms and to delay the “personality disin-
tegration”, subsequent research yielded contradictory results. In
fact, OCS/OCD were found to be associated either with less severe
delusions and formal thought disorders (Poyurovsky et al., 1999),
with higher levels of positive symptoms (Öngür and Goff, 2005;
Tiryaki and Ozkorumak, 2010) or, as shown in a recent meta-
analysis (Cunill et al., 2009), with more severe global, positive and
negative symptoms. Finally, other studies failed to reveal any dif-
ferences in schizophrenic symptoms between patients with and
without OCS/OCD comorbidity (Eisen and Rasmussen, 1993; Ber-
man et al., 1998; Hwang et al., 2000; Krüger et al., 2000; Byerlyrved.
f Neuroscience, University of
. Gramsci 14, 43126 Parma,et al., 2005).
As for the clinical outcome, following the seminal work by
Fenton and McGlashan (1986), OCS/OCD in schizophrenia have
been consistently associated with a worse clinical course, lower
quality of life, greater disability (Poyurovsky et al., 2012) and poor
social functioning (de Haan et al., 2013a, 2013b), thus challenging
the early concept of OCS/OCD as a protective factor. On the other
hand, other authors (Byerly et al., 2005) have failed to ﬁnd a re-
levant impact on functional status in schizophrenic patients. This
discrepancy has been related by some authors to a phase-depen-
dent effect of obsessive phenomena on the expression of psychotic
symptoms (Poyurovsky et al., 2004; Bottas et al., 2005).
Moreover, the heterogeneity of methodological approaches
among the studies have precluded conclusive assertions, including
the different cut-off level adopted for obsessive symptomatology
(OCS vs OCD) (de Haan et al., 2013a, 2013b). In fact OCS and OCD
might differentially impact on functioning, as recently suggested
(Üçok et al., 2011; de Haan et al., 2013a, 2013b). Therefore, a di-
mensional rather than a categorical approach might permit a more
accurate determination of the speciﬁc effect of obsessive phe-
nomena on other symptomatic dimensions and on the course of
illness in schizophrenia. Moreover, in recent years a dimensional
approach to schizophrenia has been strongly emphasized; in fact
the cross-sectional heterogeneity in clinical expression may be
better understood by identiﬁcation of distinct psychopathological
dimensions (Tandon et al., 2009; Insel, 2010). Using a dimensional
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related to delusions and compulsions to hallucinations. However,
studies adopting a dimensional perspective are scarce and, to our
knowledge, at present no studies investigated the impact of OC
dimension on both clinical characteristics and level of functioning
in schizophrenia. Therefore the aim of the present study was to
investigate the relationship between OC and other symptom di-
mensions in schizophrenia and the impact of OC phenomena on
social functioning.Table 1
Socio-demographic and clinical characteristics of
patients with schizophrenia.
Patients with schizophrenia (no. 60)
Age (mean7SD) 36.6710.1
Gender (males) No. 38 (63.3%)
Marital status (never married) No. 52 (86.6%)
Living alone No. 5 (8.3%)
Education (years) 11.173.5
Occupied No. 13 (21.7%)
Age at onset 23.976.5
Illness duration (years) 12.57 .7
Number of hospitalizations 4.174.3
PANSS
Positive scale 17.676.2
Negative scale 26.677.8
General psychopathology scale 45.8711.9
Disorganization 2.971.5
SOFAS 39.8713.8
SC-LF
No hospitalization 3.575.4
Relationship 1.571.3
Job 1.471.5
Entities of symptoms 1.371.1
Total Strauss-Carpenter 7.173.9
Y-BOCS
Subtotal obsessions 7.977.3
Subtotal compulsions 6.577.01
Total Y-BOCS 14.7713.3
PANSS: Positive and Negative Symptoms Scale;
SOFAS: Social and Occupational Functioning As-
sessment Scale; SC-LF: Strauss-Carpenter Level of
Functioning scale: Y-BOCS: Yale-Brown Obsessive–2. Methods
2.1. Participants
The study enrolled schizophrenic patients who sought treatment at the Psy-
chiatric Unit of the University Hospital of Parma from January 2012 to December
2012. Patients were included in the study if (1) they were aged over 17 years;
(2) they received a diagnosis of schizophrenia, according to DSM-IV criteria; (3) a
written informed consent was obtained.
The study sample was preselected in order to guarantee that the full range of
severity of the obsessive–compulsive dimension was represented: speciﬁcally, at
least the ﬁrst 25 patients with absent-mild OCS (YBOCS score lower than 16) and
the ﬁrst 25 patients with moderate–severe OCS (YBOCS higher than 15) were in-
cluded in the study.
Patients were excluded if they were affected by (1) a current mental disorder
related to a general mental condition or to a drug or alcohol abuse or dependence
(2) a cognitive disorder (Mini-Mental State Examination score lower than 25)
which might impair the compliance with testing procedures.
2.2. Procedures
All subjects completed (1) the Structured Clinical Interview for DSM-IV Dis-
orders (SCID-IV) (Mazzi et al., 2000); (2) the Positive and Negative Syndrome Scale
(PANSS) (Kay et al., 1987) for the evaluation of positive, negative and general
psychopathology symptoms; (3) the Yale-Brown Obsessive–Compulsive Scale
(YBOCS) (Goodman et al., 1989) for the assessment of OCS; (4) the Social and Oc-
cupational Functioning Scale (SOFAS) (American Psychiatric Association, 2000) and
the Strauss and Carpenter Level of Functioning Rating Scale (SC-LFRS) (Strauss and
Carpenter, 1974) for the evaluation of the level of functionality.
Five PANSS subscale scores were used: positive symptoms, negative symptoms,
disorganization, general psychopathology and total score. The disorganization score
was computed by summing the items of conceptual disorganization (P2) and
mannerisms and posturing (G5).
According to DSM-IV diagnostic criteria (American Psychiatric Association,
2000), recurrent and persistent thoughts which were not related to individual
delusional themes and hallucinations and were recognized by the patient as in-
trusive, inappropriate and a product of his/her own mind were considered as ob-
sessions. Similarly, repetitive behaviors that the person felt driven to perform in
response to an obsession and that were not interrelated with the content of de-
lusions and/or hallucinations were deﬁned as compulsions.
In order to guarantee an adequate cooperation to the assessment, patients were
interviewed by a trained psychiatrist after the resolution of the acute phase of
illness.
2.3. Statistical analysis
Pearson correlation analysis (two tailed) was used to evaluate the association
between OCS, positive, disorganization, negative and general psychopathology
symptoms.
Since the OCS severity did not seem to follow a normal distribution, con-
sidering the mean and the SD of the Y-BOCs score, the sample was divided into
three sub-groups according to the YBOCS score: schizophrenia patients without
OCS, with mild OCS (Y-BOCSr7) and with severe OCS (Y-BOCSZ8). Then, the
clinical features were compared in the three groups of patients using the one-way
analysis of variance.
Two linear regression analyses (step wise method) were used to evaluate the
effect of OCS, positive, disorganization and negative symptoms, age, gender, age at
onset and illness duration (independent variables) on SOFAS or SC-LFRS scores
(dependent variables). Since OCS were highly correlated with the general psycho-
pathological symptoms, latter symptoms did not enter in regression analyses as
independent variable to avoid redundancy.
All statistical analyses were performed with SPSS for Windows (version 20.0,
SPSS Inc., Chicago, IL, USA).3. Results
3.1. Participants
Sixty patients, 38 males (63.3%) and 22 females (36.7%) were
enrolled into the study. The mean age of the patients was of
36.6710.1 years; the mean age at onset of schizophrenia was
23.976.5 years, while the main duration of illness was 12.579.7
years (Table 1).
3.2. Association between symptoms
Neither Y-BOCS total score (14.7713.3; median¼11.5; range:
0–36) nor subtotal obsessions or compulsions scores were asso-
ciated with PANSS scores with the only exception of the general
psychopathology symptoms score (Table 2).
No association was found between speciﬁc PANSS and Y-BOCS
items.
Patients with mild or severe OCS and patients without OCS did
not differ on positive (14.073.6 vs 18.176.3 vs 18.676.76;
F¼1.85; p¼0.16), negative (23.479.8 vs 26.677.7 vs 6.971.8;
F¼1.15; p¼0.32) and disorganization (4.671.8 vs 5.772.8 vs
6.172.8; F¼0.93; p¼0.39) PANSS subscales scores.
3.3. Symptoms and level of functionality
Stepwise linear regression showed that the level of function-
ality, both SOFAS (Table 3) and SC-LF scores (Table 4) wasCompulsive Scale.
Table 2
Pearson correlation among symptoms in patients with schizophrenia.
Y-BOCS scores
PANSS scores Ossessions Compulsions Total
Positive ρ 0.003 0.11 0.06
p 0.97 0.38 0.63
Negative ρ 0.11 0.004 0.05
p 0.40 0.97 0.66
General Psychopathology ρ 0.35 0.31 0.36
p 0.005 0.013 0.005
Disorganization ρ 0.01 0.10 0.05
p 0.90 0.41 0.68
Total ρ 0.26 0.24 0.27
p 0.03 0.03 0.03
Table 3
Effect of symptoms on level of functionality (SOFAS score) in patients with
schizophrenia.
Social and Occupational Functioning Assessment Scale
R2 β t p
STEP 1 0.29
PANSS positive scale 0.53 4.8 o0.001
STEP 2 0.39 –
PANSS positive scale 0.50 4.9 o0.001
PANSS negative scale 0.33 3.2 0.003
STEP 3 0.46
PANSS positive scale 0.49 0.9 o0.001
PANSS negative scale 0.31 3.2 0.002
Total YBOCS 0.24 2.5 0.01
Independent variables entered in the analysis were: age, gender, age at onset, ill-
ness duration, Y BOCS and PANSS score. PANSS general psychopathological score
did not enter since its high correlation with Y-BOCS scores.
Table 4
Effect of symptoms on level of functionality (SC-LF score) in patients with
schizophrenia.
Strauss Carpenter- Level of Functioning score
R2 β t p
Step 1 0.16
PANSS positive scale – 0.40 3.4 0.001
Step 2 0.26
PANSS positive scale – 0.37 3.3 0.002
PANSS negative scale – 0.30 2.681 0.01
Step 3 0.33
PANSS positive scale – 0.36 3.3 0.002
PANSS negative scale – 0.29 2.6 0.01
Total Y-BOCS – 0.27 2.4 0.01
Independent variables entered in the analysis were: age, gender, age at onset, ill-
ness duration, Y-BOCS and PANSS score, except for PANSS general psychopatolo-
gical score did not enter since its was highly correlated with Y-BOCS scores.
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Y-BOCS total score. When Y-BOCS total score was collapsed into
subtotal obsessions and compulsions scores, an inverse relation-
ship was maintained only between functioning and compulsions.
3.4. Drug treatment
All patients were treated with antipsychotics. Patients who had
moderate–severe OC symptoms (Y-BOCS score higher than 15)
(N¼26) also received a serotoninergic drug.
Fifty-ﬁve patients (91.7%) were treated with oral antipsychotics
and the remaining 5 patients (8.3%) received a long-acting anti-
psychotic. Twenty-one patients (35%) were receiving a ﬁrst gen-
eration antipsychotic (FGA) and 39 (65%) a second generation
antipsychotic (SGA). Five patients (8.3%) were treated with cloza-
pine. The mean chlorpromazine equivalent dose was 4327
121 mg/day.4. Discussion
To our knowledge this is the ﬁrst study adopting a dimensional
approach to investigate the effect of OCS on both symptom ex-
pression and social functioning in schizophrenia.
In line with previous data (Byerly et al., 2005), the present
research showed that OCS were not related with positive and
disorganization symptoms, thus suggesting that OCS exert neither
a worsening (Öngür and Goff, 2005; Cunill et al., 2009; Tiryaki and
Ozkorumak, 2010) nor a mitigating effect (Poyurovsky et al., 1999)
on positive and disorganization symptoms severity.
Further, our data failed to replicate the results by Guillem et al.
(2009) who found a strong positive relationship between obses-
sions and delusions and between hallucinations and compulsions.
We speculate that the lack of association between obsessive di-
mension and psychotic symptoms is explained by the narrow
deﬁnition of OCS adopted in the present study which implied
strictly egodystonic features (i.e. typical OCS with insight and not
related to positive symptoms). In fact broader deﬁned OCS might
result less distinguishable from delusions.
In contrast with previous studies (Tibbo et al., 2000; Lysaker
et al., 2000; Hwang et al., 2000; Cunill et al., 2009) we were unable
to ﬁnd a relationship between OCS and negative symptoms; this
ﬁnding may be explained by the different methodological ap-
proaches (dimensional vs categorical) used and by the different
stage of illness at the assessment (long lasting illness vs early or
later phases of illness) (Poyurovsky et al., 1999; Lysaker et al.,
2000; Hwang et al., 2000). The high correlation found between
OCS and the PANSS general psychopathological symptoms may be
due to the fact that this dimension represents a heterogeneous
construct, including symptoms, such as anxiety and agitation,
probably secondary to other dimensions. In the present study, OCS,
that “cause marked anxiety or distress” (American Psychiatric
Association, 2000), might increase PANSS general psychopatholo-
gical score, thus explaining the high correlation found between
them.
Taken together, the present results suggest a lack of association
between OCS and psychotic severity. This is in line with recent
literature which views schizophrenia as a heterogeneous and
complex syndrome constituted by relatively distinct psycho-
pathological dimensions (Keshavan et al., 2008; Tandon, et al.,
2009). The signiﬁcant overlap in structures involved in both dis-
orders (in particular shared cortical–subcortical pathways) may
explain the frequent co-occurrence of OC and schizophrenia
symptoms (Bottas et al., 2005; Tonna et al., in press). As for the
level of functionality, our results show a negative effect of OC
phenomena on social functioning, since both SOFAS and SC-LFRS
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impact was still present after controlling for the severity of posi-
tive, disorganization and negative symptoms (together with age,
gender, age at onset and illness duration). Therefore, present data
do not support the hypothesis of a protective role of OCS on
functional decline in schizophrenia, as suggested by early in-
vestigators (Stengel, 1945; Rosen, 1957).
In line with more recent studies (Hwang and Opler, 2009;
Poyurovsky et al., 2012; de Haan et al., 2013a, 2013b), the present
results suggest that OCS, independently from psychotic and ne-
gative symptoms, contribute to functional impairment during the
course of illness, conﬁrming their poor prognostic signiﬁcance.
These conﬂicting results might be explained by a phase-dependent
effect of OC dimension on functional level, with OCS/OCD con-
ferring greater impairment in chronic schizophrenia and a pro-
tective effect in early stages (Bottas et al., 2005). Otherwise, as
more recently suggested (Üçok et al., 2011; de Haan et al., 2013a,
2013b), OCS and OCD might have a different impact on functioning
in schizophrenia, with a mitigating and a worsening effect re-
spectively. Nevertheless, as a distinct psychopathological dimen-
sion, OC phenomena in schizophrenia result associated to a worse
impairment in social functioning and quality of life, consistently
with the ﬁndings of most recent studies (Lysaker and Whitney,
2009; Tiryaki and Ozkorumak, 2010; de Haan et al., 2013a, 2013b;
Üçok et al., 2014).
Interestingly, our results indicate a major impact of compul-
sions rather than obsessions on the level of functionality. This
ﬁnding may be partially explained by the use of SOFAS and SCL-FS
since they mostly investigate behavioral domains of functioning.
The ﬁnding that OCS in schizophrenia adversely impact on
functioning and have a poor prognostic signiﬁcance support the
view of recognizing OCS as a clinical important symptom cluster in
schizophrenia (Tonna et al., 2015). Future research is needed to
elucidate if OCS schizophrenia comorbidity may represent a spe-
ciﬁc subtype of schizophrenia.
Our study presents the following limitations: ﬁrst, the cross-
sectional design of the study cannot exclude that OCS may ﬂuc-
tuate during the course of the disease with the relationship be-
tween OCS and other schizophrenic symptoms or functioning
changing over time. Second, since cognitive symptoms were not
evaluated in the present study, the effect of obsessive dimension
on functioning might not be controlled for the effect of cognitive
dysfunction. Therefore, our results should be conﬁrmed taking
into account the effect of cognitive dimension.5. Conclusions
In conclusion, OC, psychotic and negative symptoms appear to
be independent dimensions that separately inﬂuence the level of
functioning in patients with schizophrenia.
Furthermore, in schizophrenia OC dimension should be care-
fully investigated due to its important prognostic implications on
functional impairment.References
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